Towards Healthcare
Life Science Consulting Market to Reach USD 84.83 Bn by 2034

Life Science Consulting Market Thrives on AI Integration

Based on market forecasts, the life science consulting sector will expand from USD 34.82 billion in 2024 to USD 84.83 billion by 2034, experiencing a CAGR of 9.38%. Globally rising regulatory complexities and demand for cost reduction are fueling the global market growth. North America led the market due to the widespread R&D investment in pharma & biotech companies.

  • Insight Code: 6263
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The life science consulting market in 2025 is valued at USD 38.08 billion and is projected to climb to USD 84.83 billion by 2034, with a CAGR of 9.38% over the forecast period.

North America is currently leading the life science consulting market due to the wider investment in the pharmaceutical and biotechnology companies.

Some key players include McKinsey & Company, Deloitte, IQVIA, PwC, and Accenture.

They do market research, regulatory guidance, strategy development, operational support, and technology adoption.

DBT, Consultancy. In, pharma dept.gov, PCI, CDSCO, BCIL, BIRAC, DSIR.